Sivik Global Healthcare LLC Argenx Se Transaction History

Sivik Global Healthcare LLC

  • $236 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023
BUY
$360.14 - $422.58 $1.08 Million - $1.27 Million
3,000 New
3,000 $1.17 Million
Q3 2021

Nov 12, 2021
SELL
$295.0 - $350.58 $1.77 Million - $2.1 Million
-6,000 Closed
0 $0
Q2 2021

Aug 10, 2021
SELL
$257.11 - $319.92 $128,555 - $159,960
-500 Reduced 7.69%
6,000 $1.81 Million
Q1 2021

May 12, 2021
BUY
$268.3 - $380.31 $1.74 Million - $2.47 Million
6,500 New
6,500 $1.79 Million

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Sivik Global Healthcare LLC Portfolio

Follow Sivik Global Healthcare LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email